| Old Articles: <Older 23191-23200 Newer> |
 |
The Motley Fool May 14, 2007 Brian Lawler |
Sour Results for Nektar Nektar Therapeutics announces its first-quarter financial results and plans for the future. Investors, take note.  |
The Motley Fool May 14, 2007 Mike Cianciolo |
United Auto Group's Diversity Pays Off The automotive retailer passes the competition, posting strong sales gains. Is this a decent buy for investors?  |
The Motley Fool May 14, 2007 Matt Koppenheffer |
Dueling Fools: Chipotle Bear Investors, go ahead and eat the burritos, but pass on the stock.  |
The Motley Fool May 14, 2007 Ryan Fuhrmann |
Dueling Fools: Chipotle Bull Rebuttal Fiery growth is tough to sustain -- but not impossible. Investors need to see that Chipotle has a number of key ingredients to warrant consideration as the next great restaurant concept.  |
The Motley Fool May 14, 2007 Matt Koppenheffer |
Cerberus Gets the Nod From Daimler Private equity fund Cerberus announced that it will acquire an 80.1% interest in Chrysler. Investors, take note.  |
The Motley Fool May 14, 2007 Ryan Fuhrmann |
Sara Lee Seeks the Right Recipe There are positive signs, but the company remains a work in progress. Investors, in the land of opportunity cost, the competition is winning on the income front, and each rival is also in the process of right-sizing its food-brand portfolio.  |
The Motley Fool May 14, 2007 Brian Lawler |
Mylan Goes on a Drug Binge The generic drugmaker makes a hefty acquisition, but it's hard to say at this point how good of a deal this is for shareholders.  |
The Motley Fool May 14, 2007 Mike Havrilla |
Investors Tire of Inspire Pharmaceuticals Shares are down about 10% recently, despite approval for AzaSite.  |
The Motley Fool May 14, 2007 |
Caribou's Not-So-Big Bucks: Fool by Numbers Caribou Coffee released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...  |
The Motley Fool May 14, 2007 Mike Cianciolo |
Caribou's Still Grounded The coffee specialist brews higher sales but still isn't earning. It doesn't look like this stock is providing investors what they crave.  |
| <Older 23191-23200 Newer> Return to current articles. |